Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women
Abstract A decrease in the intracellular level of nicotinamide adenine dinucleotide (NAD+), an essential coenzyme for metabolic activity, causes various age-related diseases and metabolic abnormalities. Both in-vivo and in-vitro studies have shown that increasing certain NAD+ levels in cell or tissu...
Main Authors: | Yuichiro Fukamizu, Yoshiaki Uchida, Akari Shigekawa, Toshiya Sato, Hisayuki Kosaka, Takanobu Sakurai |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-18272-y |
Similar Items
-
Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects
by: Keisuke Okabe, et al.
Published: (2022-04-01) -
Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study
by: Mijin Kim, et al.
Published: (2022-02-01) -
Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain
by: Chidambaram Ramanathan, et al.
Published: (2022-01-01) -
Subacute Toxicity Study of Nicotinamide Mononucleotide via Oral Administration
by: Yingnan You, et al.
Published: (2020-12-01) -
Metabolic engineering of Escherichia coli for biosynthesis of β‐nicotinamide mononucleotide from nicotinamide
by: Yang Liu, et al.
Published: (2021-11-01)